Royalty Pharma | Sustainability Performance

https://www.royaltypharma.com/

Invests in and manages pharmaceutical royalties and intellectual property. Activities include acquiring rights to drug products, monitoring revenue streams, and managing legal and regulatory obligations, while providing capital to support ongoing development projects.

1996

United States

51 - 200 employees

Biotechnology

$1B - 10B in revenue

$1B - 10B in profitability

Submit or report inaccurate data Download Company Insights

Sustainability Ranking & Industry Benchmark

#9616

Overall

#2148

in United States

#207

in Biotechnology

Sustainability Maturity

Sustainability Intent

Available in
Scale package

Access

Beyond Top 100

Overview

Environmental

Carbon emissionsNature and biodiversityNature riskClimate risk

Social

Diversity and inclusionPay gapsExternalities

Governance

TargetsSDG ImpactESG scores and exclusionsB-corp & CDP

Financial Data

Business performanceCapital & innovationAnalyst projections

View similiar companies

Envista

United States, Hospital & Health Care, Medical Device

Encompass health

United States, Hospital & Health Care, Hospital & Health Care

Cigna Healthcare

United States, Hospital & Health Care, Hospital & Health Care

Female engagement

50% 2024

Laggard

Externalities

101.0K $, 2024

Leading

Market cap

33.9B $, 2026▲39.4% YoY

Revenue

2.4B $, 2025▲4.8% YoY

R&D intensity

19.01% 2025

Controversy level

Very Low

Low

Noticeable

High

Severe

Download Controversy Analysis

Royalty Pharma plc, US/Dublin pharma royalty investment major, has faced multiple US shareholder class actions over alleged inadequate disclosure of multiple biotech royalty investment customer concentration risks affecting Royalty Pharma's share price, plus periodic SEC enforcement scrutiny on alleged inadequate disclosure of competitive market displacement affecting US institutional shareholders.

Carbon emissions breakdown

Reveal data for 2 credits

KPI	Metric	Year
		2020	2021	2022	2023	2024	Benchmark
*******	*******	-	*******	*******	*******	*******	*******
*******	*******	-	*******	*******	*******	*******	*******

Biodiversity impact

Reveal data for 2 credits

KPI	Metric	Year
		2020	2021	2022	2023	2024	Benchmark
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******

Land use

Reveal data for 2 credits

KPI	Metric	Year
		Infinity	Infinity	Infinity	Infinity	Infinity	Benchmark
*******	*******	-	-	-	-	-	*******
*******	*******	-	-	-	-	-	*******
*******	*******	-	-	-	-	-	*******
*******	*******	-	-	-	-	-	*******
*******	*******	-	-	-	-	-	*******

Diversity & inclusion

Reveal data for 3 credits

KPI	Metric	Year
		2020	2021	2022	2023	2024	Benchmark
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******

Pay gap breakdown

Reveal data for 1 credit

KPI	Metric	Year
		2020	2021	2022	2023	2024	Benchmark
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	-	-	-	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	-	-	-	-	-	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******

Externalities

Reveal data for 1 credit

KPI	Metric	Year
		2020	2021	2022	2023	2024	Benchmark
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******

SDG impact (historical)

Reveal data for 5 credits

KPI	Metric	Year
		2019	2020	2021	2022	2023	Benchmark
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******
*******	*******	*******	*******	*******	*******	*******	*******

Reporting

Sustainability Report

Available

Not committed to key sustainability initiatives

Sustainability employees

Available in
Scale package

Access

Controversy level

Very Low

Low

Noticeable

High

Severe

Download Controversy Analysis

Royalty Pharma plc, US/Dublin pharma royalty investment major, has faced multiple US shareholder class actions over alleged inadequate disclosure of multiple biotech royalty investment customer concentration risks affecting Royalty Pharma's share price, plus periodic SEC enforcement scrutiny on alleged inadequate disclosure of competitive market displacement affecting US institutional shareholders.

Royalty Pharma | Sustainability Performance

Sustainability Ranking & Industry Benchmark

Sustainability Maturity

Sustainability Intent

Available in Scale package

View similiar companies

Female engagement

Controversy level

Carbon emissions breakdown

Climate risk

Nature risk

Production loss

Revenue at risk

Assets exposed to sensitive locations

Biodiversity loss in km²

Biodiversity loss in CO2e

Potential species loss

Biodiversity impact

Land use

Diversity & inclusion

Pay gap breakdown

Externalities

Revenue & EBITDA

Margin trends

R&D intensity

Return on invested capital

Analyst revenue estimates & actuals

Environmental policy coverage

Overall score

Environment

Social

Governance

Exclusion screening

CDP Scores

SDG impact

SDG impact (historical)

Reporting

Sustainability employees

Available in Scale package

Royalty Pharma | Sustainability Performance

Sustainability Ranking & Industry Benchmark

Sustainability Maturity

Sustainability Intent

Available in Scale package

View similiar companies

Female engagement

Controversy level

Carbon emissions breakdown

Climate risk

Nature risk

Production loss

Revenue at risk

Assets exposed to sensitive locations

Biodiversity loss in km²

Biodiversity loss in CO2e

Potential species loss

Biodiversity impact

Land use

Diversity & inclusion

Pay gap breakdown

Externalities

Revenue & EBITDA

Margin trends

R&D intensity

Return on invested capital

Analyst revenue estimates & actuals

Environmental policy coverage

Overall score

Environment

Social

Governance

Exclusion screening

CDP Scores

SDG impact

SDG impact (historical)

Reporting

Sustainability employees

Available in Scale package

Available in
Scale package

Available in
Scale package

Available in
Scale package

Available in
Scale package